Mycosis fungoides: A challenge for the diagnosis
Received Date : 24 Apr 2019
Accepted Date : 23 Jun 2019
Doi: 10.1016/j.jons.2019.06.002 - Article's Language: EN
J Oncol Sci 5 (2019) 70-72
This is an open access article under the CC BY-NC-ND license
Mycosis fungoides (MF) is the most common primary cutaneous T-cell lymphoma. This cancer characteristically affects the skin, causing different types of skin lesions that progress slowly through several stages, although not all people with the condition progress through all stages.We present a case of MF in a 32-year-old female patient with many years of nonspecific eczematous and psoriasiform skin lesions and non-diagnostic biopsies. The diagnosis of MF can be very difficult and misleading. The wide range of clinical and pathological presentations of MF makes this disease a challenge for diagnosis and, therefore, requires an accurate differential diagnosis integrated by the patient's clinic together with the histological and immunological findings.
  1. Mu~noz-Gonzalez H, Molina-Ruiz AM, Requena L. Clinicopathologic variants of mycosis fungoides. Actas Dermosifiliogr. 2017;108(3):192e208. 10.1016/j.adengl.2017.02.010. [Crossref] 
  2. Beyer M, M€obs M, Humme D, Sterry W. Pathogenesis of mycosis fungoides. J Dtsch Dermatol Gest. 2011;9(8):594e598. 0387.2011.07635.x. [Crossref]  [PubMed] 
  3. Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol. 2013;149(11):1295. jamadermatol.2013.5526. [Crossref]  [PubMed] 
  4. Larocca C, Kupper T. Mycosis fungoides and Sezary syndrome. Hematol Oncol Clin N Am. 2019;33(1):103e120. [Crossref]  [PubMed]  [PMC] 
  5. Cervini AB, Torres-Huamani AN, Sanchez-La-Rosa C, et al. Mycosis fungoides: experience in a pediatric hospital. Actas Dermosifiliogr. 2017;108(6):564e570. [Crossref] 
  6. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med. 2004;350(19):1978e1988. [Crossref]  [PubMed]  [PMC] 
  7. Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, riskstratification, and management. Am J Hematol. 2016;91(1):151e165. https:// [Crossref]  [PubMed]  [PMC] 
  8. Kazakov D, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004;18(4):397e415. 10.1111/j.1468-3083.2004.00937.x. [Crossref]  [PubMed] 
  9. Ahn CS, ALSayyah A, Sangüeza OP. Mycosis fungoides. Am J Dermatopathol. 2014;36(12):933e951. [Crossref]  [PubMed] 
  10. Virmani P, Myskowski PL, Pulitzer M. Unusual variants of mycosis fungoides. Diagn Histopathol. 2016;22(4):142e151. j.mpdhp.2016.04.004. [Crossref]  [PubMed]  [PMC] 
  11. Jaque A, Mereniuk A, Walsh S, et al. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients. Int J Dermatol. February 2019:1e7. [Crossref]  [PubMed] 
  12. Berg S, Villasenor-Park J, Haun P, Kim EJ. Multidisciplinary management of mycosis fungoides/Sezary syndrome. Curr Hematol Malig Rep. 2017;12(3): 234e243. [Crossref]  [PubMed]